Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
about
Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cellsProgression of cutaneous melanoma: implications for treatmentTransmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteasesBasigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblastsCompensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysisFAK competes for Src to promote migration against invasion in melanoma cells.Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.β-Lapachone suppresses the lung metastasis of melanoma via the MAPK signaling pathway.Fibroblasts protect melanoma cells from the cytotoxic effects of doxorubicin.Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapyCXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity.A case report - Volatile metabolomic signature of malignant melanoma using matching skin as a control.Dual effects of collagenase-3 on melanoma: metastasis promotion and disruption of vasculogenic mimicry.A Novel Fully Humanized 3D Skin Equivalent to Model Early Melanoma Invasion.Downregulation of matrix metalloproteinase-2 (MMP-2) utilizing adenovirus-mediated transfer of small interfering RNA (siRNA) in a novel spinal metastatic melanoma model.Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cellsEthanol extract of Lophatheri Herba exhibits anti-cancer activity in human cancer cells by suppression of metastatic and angiogenic potential.Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.Predicting and preventing melanoma invasiveness: advances in clarifying E2F1 function.Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications.In vivo optical imaging of MMP2 immuno protein antibody: tumor uptake is associated with MMP2 activityAntimetastatic pectic polysaccharide from Decalepis hamiltonii; galectin-3 inhibition and immune-modulation.A novel matrix metalloproteinase-2 inhibitor triazolylmethyl aziridine reduces melanoma cell invasion, angiogenesis and targets ERK1/2 phosphorylation.Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration.The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts.MMP19 is upregulated during melanoma progression and increases invasion of melanoma cells.Downregulation of CCN3 expression as a potential mechanism for melanoma progression.Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment.Endogenous production of nitric oxide contributes to proliferation effect of vascular endothelial growth factor-induced malignant melanoma cell.Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling.Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.Angiostatin generation by human tumor cell lines: involvement of plasminogen activators.Prognostic significance of the expression of nuclear eukaryotic translation initiation factor 5A2 in human melanoma.MMP-2, TIMP-2 and MT1-MMP are differentially expressed in lesional skin of melanocytic nevi and their expression is modulated by UVB-light.The extracellular matrix remodeled: Interdependency of matrix proteolysis, cell adhesion, and force sensing.Enzyme-responsive multistage vector for drug delivery to tumor tissue.High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma.Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography.Simultaneous induction of matrix metalloproteinase-9 and interleukin 8 by all-trans retinoic acid in human PL-21 and NB4 myeloid leukaemia cells.
P2860
Q24648424-F7E2077D-331C-4736-BC09-8D397E54BE61Q27001734-1DCE5F47-DBC1-4818-A910-D8F7B06A688EQ27335558-4FA941DB-11E0-4B40-A920-6084B1D97FA5Q28216628-11E6D58C-B8F3-4A82-9B55-F8978D2507B7Q29615193-3DE45F08-3D14-4A12-846D-67F215A56E29Q30009333-2D6A2784-28FE-46E0-91EB-1A12A040FF2DQ33223885-AFF4822E-947E-4BB4-AA32-93F4DD41C00DQ33648101-560F4699-13A5-4687-8321-C6273120B1E4Q34164261-60FAD182-8F7E-44AA-82A5-EFB5C6164CEAQ34748331-3DA56DF2-1B6E-4D3D-83F4-CE84D38E8072Q35583851-C6F925B0-86D2-4562-9B9E-AE39158A1FC1Q35651462-D534CEEF-0A4C-4212-93A6-CEFA598FA910Q35832252-5A780086-B978-42B3-8C35-BB0EB56C4A22Q36262832-BB803519-36BA-4A12-8454-0547C261ED44Q36496325-4C04F248-5A03-40A2-93D2-D76C1F61DBA1Q36644626-B9E24BAD-1610-4E1B-8471-1B7261E4D5B6Q37308167-29B927D3-AA8A-4510-95CB-A65C70B687C5Q37390503-94F67835-E3B1-45C1-BC9A-8B0D1E869160Q37572760-2E3C7852-0627-4D4E-8B7B-AA5A4C7120F8Q37809859-5DE6810B-2CFD-4423-94BF-C8078D5B2A86Q38196881-67133AB4-73CE-4456-A80D-F208518E72B4Q38672056-5DE07AC3-4E94-4370-8FE9-3D664AAC4558Q38979750-B164FD4D-1F85-473B-BDDC-85F0C9083335Q39061829-69E581BC-C260-44BF-AD91-A95DE3501CCDQ39063857-97DBFD43-9D67-4B95-836B-14D6A15F9FD6Q39623323-776B25E6-94D6-4BDF-9137-BB79138A91FEQ39748560-AD3F585A-0F82-4C26-8D85-0B6607B822FFQ40060499-B170CB51-AC55-4433-BC5B-F31D4626C89DQ40153829-D52E7E6B-C5A0-48AA-BE68-FCA64AE81475Q40347372-801310D6-E974-4A0D-827D-60932A147D52Q40548011-5B63EE44-FE5C-4A50-A46C-11E667C85994Q40872675-BF908A7E-C75A-4AA9-81BC-766C32E51B3FQ40875511-0B1F8CB0-5624-40FE-A1AE-F15DBB8932EAQ42031208-78E514E0-BD69-41B2-9966-5737BA7EDB48Q42524110-F3017180-6D1C-4E2D-995C-3B8069455DF6Q42617197-FC5C1064-C038-463A-89F3-DB3E98BE2EB5Q42695589-08C4DCC3-6319-4DDA-9B4D-9D51AD42BFBDQ43861059-020AB331-5BA6-43D3-AA5F-4F4C64A241F4Q43996937-B1EA2FD8-9A28-43C0-A018-C51510A10F71Q44078263-82533D6F-5D2F-402C-B30A-CF24A1548CF7
P2860
Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Matrix metalloproteinases in h ...... tes with melanoma progression.
@en
type
label
Matrix metalloproteinases in h ...... tes with melanoma progression.
@en
prefLabel
Matrix metalloproteinases in h ...... tes with melanoma progression.
@en
P2093
P2860
P356
P1476
Matrix metalloproteinases in h ...... tes with melanoma progression.
@en
P2093
Cornelissen IM
Hofmann UB
Westphal JR
Zendman AJ
van Muijen GN
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690763
P407
P577
1999-11-01T00:00:00Z
P5875
P6179
1027404259